What is MedArbor?
MedArbor Diagnostics operates as a full-service, accredited clinical laboratory headquartered in the Philadelphia region. The organization provides a comprehensive suite of diagnostic solutions, ranging from molecular diagnostics and toxicology to specialized wellness panels. By focusing on the identification of pathogens and the root causes of complex health conditions, MedArbor serves as a vital link in the patient care continuum. Their service model is specifically engineered to support clinicians, healthcare systems, and long-term care facilities, ensuring that medical professionals have access to the actionable data necessary for informed clinical decision-making and improved patient outcomes.
How much funding has MedArbor raised?
MedArbor has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in MedArbor
PPP
Public-Private Partnership
What's next for MedArbor?
With this late-stage capital infusion, MedArbor is well-positioned to accelerate its operational expansion and enhance its technological capabilities. The strategic allocation of these funds will likely focus on increasing laboratory throughput, integrating advanced diagnostic methodologies, and broadening the reach of their wellness panel offerings. As the healthcare landscape shifts toward more personalized and rapid diagnostic interventions, MedArbor's ability to maintain high-quality, reliable testing services will be a key driver of its long-term growth trajectory. The company remains focused on scaling its infrastructure to meet the rising demand for sophisticated diagnostic support in the clinical and long-term care sectors.
See full MedArbor company page
